These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 21575307)
1. Pulmonary artery pressure in chronic obstructive pulmonary disease without resting hypoxaemia. Lee JH; Oh YM; Seo JB; Lee YK; Kim WJ; Sheen SS; Kim TH; Lee JH; Kim EK; Lee JS; Huh JW; Lim SY; Yoon HI; Shin TR; Lee SM; Lee SY; Lee SD Int J Tuberc Lung Dis; 2011 Jun; 15(6):830-7. PubMed ID: 21575307 [TBL] [Abstract][Full Text] [Related]
2. [Pulmonary hypertension in patients with chronic obstructive pulmonary disease: clinical characteristics and risk factors]. Wang T; Mao Y; Sun Y; Hou W; Feng Y; Qu H Zhonghua Nei Ke Za Zhi; 2015 Dec; 54(12):1037-40. PubMed ID: 26887371 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease. Jo YS; Park JH; Lee JK; Heo EY; Chung HS; Kim DK Int J Chron Obstruct Pulmon Dis; 2017; 12():2433-2443. PubMed ID: 28860738 [TBL] [Abstract][Full Text] [Related]
4. Exercise hypoxaemia as a predictor of pulmonary hypertension in COPD patients without severe resting hypoxaemia. Nakahara Y; Taniguchi H; Kimura T; Kondoh Y; Arizono S; Nishimura K; Sakamoto K; Ito S; Ando M; Hasegawa Y Respirology; 2017 Jan; 22(1):120-125. PubMed ID: 27471142 [TBL] [Abstract][Full Text] [Related]
5. Initial risk assessment for pulmonary hypertension in patients with COPD. Gartman EJ; Blundin M; Klinger JR; Yammine J; Roberts MB; Dennis McCool F Lung; 2012 Feb; 190(1):83-9. PubMed ID: 22094960 [TBL] [Abstract][Full Text] [Related]
6. Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients. Cazzola M; Mantero A; Santus P; Carlucci P; Mondoni M; Bosotti L; Centanni S Pulm Pharmacol Ther; 2007; 20(3):258-64. PubMed ID: 16600647 [TBL] [Abstract][Full Text] [Related]
7. Systemic inflammation in patients with COPD and pulmonary hypertension. Joppa P; Petrasova D; Stancak B; Tkacova R Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829 [TBL] [Abstract][Full Text] [Related]
8. Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Boutou AK; Karrar S; Hopkinson NS; Polkey MI Respiration; 2013; 85(2):126-31. PubMed ID: 22759351 [TBL] [Abstract][Full Text] [Related]
9. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population. Hachulla E; Clerson P; Airò P; Cuomo G; Allanore Y; Caramaschi P; Rosato E; Carreira PE; Riccieri V; Sarraco M; Denton CP; Riemekasten G; Pozzi MR; Zeni S; Mihai CM; Ullman S; Distler O; Rednic S; Smith V; Walker UA; Matucci-Cerinic M; Müller-Ladner U; Launay D; Rheumatology (Oxford); 2015 Jul; 54(7):1262-9. PubMed ID: 25596413 [TBL] [Abstract][Full Text] [Related]
10. Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance. Yilmaz R; Gencer M; Ceylan E; Demirbag R J Am Soc Echocardiogr; 2005 Aug; 18(8):873-81. PubMed ID: 16084341 [TBL] [Abstract][Full Text] [Related]
11. Association of Anemic Hypoxia and Increased Pulmonary Artery Systolic Pressure in Patients With Systemic Lupus Erythematosus. Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1702-11. PubMed ID: 26018410 [TBL] [Abstract][Full Text] [Related]
12. The role of pulmonary pressure/cardiac index to identify pulmonary hemodynamic responders to acute oxygen breathing pulmonary hypertension COPD patients. Lupi-Herrera E; Sandoval J; Efren Santos L; Pulido T; Rosas-Peralta M Arch Cardiol Mex; 2011; 81(3):208-16. PubMed ID: 21975235 [TBL] [Abstract][Full Text] [Related]
13. Exercise-Induced Abnormal Increase of Systolic Pulmonary Artery Pressure in Adult Patients With Sickle Cell Anemia: An Exercise Stress Echocardiography Study. de Lima-Filho NN; Figueiredo MS; Vicari P; Cançado R; Carvalho AC; Bordin JO; Campos O Echocardiography; 2016 Dec; 33(12):1880-1890. PubMed ID: 25521187 [TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease. Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043 [TBL] [Abstract][Full Text] [Related]
15. Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension. Lacedonia D; Valerio G; Palladino GP; Carpagnano GE; Correale M; Di Biase M; Foschino Barbaro MP Rejuvenation Res; 2014 Feb; 17(1):33-9. PubMed ID: 24228853 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary function and diffusion capacity are associated with pulmonary arterial systolic pressure in the general population: The Rotterdam Study. Loth DW; Lahousse L; Leening MJG; Krijthe BP; Felix JF; Gall H; Hofman A; Ghofrani HA; Franco OH; Stricker BH; Brusselle GG Respir Med; 2017 Nov; 132():50-55. PubMed ID: 29229105 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of pulmonary hypertension in COPD patients living at high altitude. Aguirre-Franco C; Torres-Duque CA; Salazar G; Casas A; Jaramillo C; Gonzalez-Garcia M Pulmonology; 2024; 30(3):247-253. PubMed ID: 35151623 [TBL] [Abstract][Full Text] [Related]